0001493152-25-028780.txt : 20251222 0001493152-25-028780.hdr.sgml : 20251222 20251222163023 ACCESSION NUMBER: 0001493152-25-028780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251219 FILED AS OF DATE: 20251222 DATE AS OF CHANGE: 20251222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ling Geoffrey M.D. CENTRAL INDEX KEY: 0001800097 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38914 FILM NUMBER: 251592872 MAIL ADDRESS: STREET 1: C/O CATALYST BIOSCIENCES, INC. STREET 2: 611 GATEWAY BOULEVARD, SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celularity Inc CENTRAL INDEX KEY: 0001752828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 831702591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (908) 768-2170 MAIL ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: GX Acquisition Corp. DATE OF NAME CHANGE: 20180912 4 1 ownership.xml 4 X0508 4 2025-12-19 0 0001752828 Celularity Inc CELU 0001800097 Ling Geoffrey M.D. C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932 1 0 0 0 0 Class A Common Stock 2025-12-19 4 A 0 67416 0.00 A 111795 D These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025. /s/ Geoffrey Ling, MD 2025-12-22